Related Experiment Video
Updated: Jun 20, 2025

06:59
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.6K
Wait-times benchmarks for risk-based prioritization in transcatheter aortic valve implantation: a simulation study
Rafael N Miranda1, Peter C Austin1,2, Stephen E Fremes1,2,3,4
1Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto M5T 3M6, Canada.
Summary
Prioritizing high-risk patients for transcatheter aortic valve implantation (TAVI) reduces mortality and hospitalizations. However, this strategy may lead to long wait times for lower-risk patients, necessitating careful planning.
Area of Science:
- Cardiovascular Medicine
- Health Services Research
- Medical Simulation
Background:
- Increasing demand for transcatheter aortic valve implantation (TAVI) has led to extended wait times and adverse patient outcomes.
- Risk-based prioritization and wait-time benchmarks are crucial for equitable access to TAVI.
Purpose of the Study:
- To evaluate the impact of risk-based prioritization strategies on patient outcomes and wait times for transcatheter aortic valve implantation (TAVI).
- To determine optimal wait-time benchmarks for different risk groups undergoing TAVI.
Main Methods:
- Utilized simulation models to analyze a synthetic population of 50,000 individuals undergoing TAVI.
- Classified patients into low-, medium-, and high-risk groups, assigning shorter wait times to higher-risk categories.
- Assessed the effects of risk group size and wait times on waitlist mortality, hospitalizations, and urgent TAVI procedures under consistent resource constraints.
Main Results:
- Prioritizing high-risk patients with shorter wait times significantly reduced mortality (up to 29%), hospitalizations (up to 23%), and urgent TAVIs (up to 38%).
- This prioritization led to extended wait times (up to 25 weeks) for non-prioritized, low-risk patients.
- Proposed wait times: up to 3 weeks for high-risk and 7 weeks for medium-risk patients.
Conclusions:
- Faster access for higher-risk patients improves overall health outcomes but can create unacceptably long wait times for lower-risk groups in resource-limited settings.
- Healthcare decision-makers must carefully consider these trade-offs when implementing TAVI waitlist prioritization strategies.

